HK1042050A1 - Ocular tension lowering composition for topical a dministration. - Google Patents

Ocular tension lowering composition for topical a dministration.

Info

Publication number
HK1042050A1
HK1042050A1 HK02103878A HK02103878A HK1042050A1 HK 1042050 A1 HK1042050 A1 HK 1042050A1 HK 02103878 A HK02103878 A HK 02103878A HK 02103878 A HK02103878 A HK 02103878A HK 1042050 A1 HK1042050 A1 HK 1042050A1
Authority
HK
Hong Kong
Prior art keywords
tension lowering
topical
dministration
lowering composition
ocular tension
Prior art date
Application number
HK02103878A
Other languages
English (en)
Inventor
Tomihisa Yokoyama
Takashi Shiokari
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1042050A1 publication Critical patent/HK1042050A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
HK02103878A 1999-06-11 2002-05-23 Ocular tension lowering composition for topical a dministration. HK1042050A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16494599 1999-06-11
PCT/JP2000/003779 WO2000076543A1 (fr) 1999-06-11 2000-06-09 Composition permettant de reduire la tension oculaire et destinee a l'administration topique

Publications (1)

Publication Number Publication Date
HK1042050A1 true HK1042050A1 (en) 2002-08-02

Family

ID=15802847

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103878A HK1042050A1 (en) 1999-06-11 2002-05-23 Ocular tension lowering composition for topical a dministration.

Country Status (24)

Country Link
US (1) US6777436B2 (cs)
EP (1) EP1186302B1 (cs)
KR (1) KR100611543B1 (cs)
CN (1) CN1198650C (cs)
AT (1) ATE295721T1 (cs)
AU (1) AU759513B2 (cs)
BR (1) BR0011477A (cs)
CA (1) CA2376780C (cs)
CZ (1) CZ300553B6 (cs)
DE (1) DE60020230T2 (cs)
ES (1) ES2242619T3 (cs)
HK (1) HK1042050A1 (cs)
HU (1) HUP0201466A3 (cs)
IL (2) IL146917A0 (cs)
MX (1) MXPA01012752A (cs)
NO (1) NO328211B1 (cs)
NZ (1) NZ516033A (cs)
PL (1) PL200009B1 (cs)
PT (1) PT1186302E (cs)
RU (1) RU2227740C2 (cs)
TR (1) TR200103603T2 (cs)
TW (1) TWI245639B (cs)
WO (1) WO2000076543A1 (cs)
ZA (1) ZA200109943B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
EP1872783B1 (en) * 2005-04-21 2011-12-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for corneal/conjunctival disorder
ES2588437T3 (es) 2007-11-30 2016-11-02 Toltec Pharmaceuticals, Llc Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
CZ154994A3 (en) 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
DE69534339T2 (de) * 1994-02-08 2006-05-24 Novartis Ag Behandlung von normaldruckglaukom mit valsartan
DK1110551T3 (da) * 1994-03-16 2004-06-07 Sankyo Co Okulærtensionssænkende middel
JPH07324034A (ja) * 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤

Also Published As

Publication number Publication date
EP1186302A4 (en) 2004-03-24
WO2000076543A1 (fr) 2000-12-21
AU5108600A (en) 2001-01-02
NO328211B1 (no) 2010-01-11
HUP0201466A2 (en) 2002-09-28
NZ516033A (en) 2003-09-26
PL352161A1 (en) 2003-07-28
PT1186302E (pt) 2005-07-29
DE60020230T2 (de) 2006-03-09
KR20020015343A (ko) 2002-02-27
ES2242619T3 (es) 2005-11-16
IL146917A0 (en) 2002-08-14
KR100611543B1 (ko) 2006-08-10
CA2376780A1 (en) 2000-12-21
HUP0201466A3 (en) 2003-04-28
CN1198650C (zh) 2005-04-27
NO20016023D0 (no) 2001-12-10
AU759513B2 (en) 2003-04-17
ZA200109943B (en) 2003-03-03
BR0011477A (pt) 2002-03-19
CZ20014415A3 (cs) 2002-04-17
ATE295721T1 (de) 2005-06-15
PL200009B1 (pl) 2008-11-28
US20020147211A1 (en) 2002-10-10
IL146917A (en) 2006-10-31
MXPA01012752A (es) 2002-07-02
TR200103603T2 (tr) 2002-05-21
CA2376780C (en) 2008-05-06
RU2227740C2 (ru) 2004-04-27
US6777436B2 (en) 2004-08-17
NO20016023L (no) 2002-01-29
DE60020230D1 (de) 2005-06-23
EP1186302B1 (en) 2005-05-18
CZ300553B6 (cs) 2009-06-17
CN1368889A (zh) 2002-09-11
EP1186302A1 (en) 2002-03-13
TWI245639B (en) 2005-12-21

Similar Documents

Publication Publication Date Title
AU7833698A (en) Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
CA2198535A1 (en) Method of increasing testosterone
AU5557800A (en) Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
AU2467297A (en) New benzimidazole derivatives with antihistaminic activity
CA2199468A1 (en) 1,2,3,4-tetrahydroquinoxalinedione derivative
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
AU1793195A (en) Stable crystalline (6S)- and (6R)-tetrahydrofolsaure
AU4301596A (en) Transdermal preparation containing a loratidine metabolite with antihistaminic activity
HK1042050A1 (en) Ocular tension lowering composition for topical a dministration.
AU4434189A (en) An anti-human immunodeficiency virus composition
HK1045458A1 (en) Ophthalmic histtamine compositions and uses thereof.
AU4699197A (en) Wireless telecommunications system with a cdma, fdma and tdma multiple access component, especially a "jd-cdma" telecommunications system with hybrid multiple access techniques
CA2371554A1 (en) Pharmaceutical composition comprising an angiotensin ii antagonist for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy
AU674379B2 (en) Antitussive
CA2340427A1 (en) Non-sedating diphenhydramine metabolites
DE69830333D1 (de) SCHNELLÖSLICHE ARZNEIMITTELZUSAMMENSETZUNG ENTHALTEND MIKRONISiERTE AS-3201
EP0755928A4 (en) 5-AMINOFLAVONE DERIVATIVES
CA2290392A1 (en) Salts of optically active sulfoxide derivative
CA2358487A1 (en) Use of phanquinone for the treatment or prevention of memory impairment
MX9704012A (es) Conjugados de interferon.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110609